2020
Bhubaneswar (India)
Series A
CureBay is an Odisha-based healthtech company operating in the hospitals and healthcare industry, CureBay’s core mission is to bridge the gap in primary healthcare access for underserved and rural populations in India. The company leverages a tech-first, hybrid healthcare model that integrates digital platforms with a robust physical network of over 150 e-clinics and more than 1,000 trained health workers (“Swasthya Mitras”) across Odisha and Chhattisgarh, with plans to expand into Jharkhand, Bihar, Uttar Pradesh and Madhya Pradesh.
CureBay operates a hybrid healthcare and fulfillment model, connecting patients in underserved markets to healthcare providers, diagnostics, pharmacies, and hospitals both digitally and through a physical network. The business is structured around three tiers and its primary revenue streams are:
Hub: Centralized operations and technology platform
Spoke: Regional e-clinics staffed by trained health workers
Satellite: Local health centers for last-mile service delivery.
Teleconsultation Fees: Patients pay per session for remote consultations with healthcare professionals.
Healthcare Services: Fees from diagnostic tests, medicine dispensing, vaccination programs, and other in-clinic services.
Subscription Models: Recurring revenue from premium healthcare plans and annual memberships offering enhanced access and benefits.
Partnerships and Collaborations: Revenue from collaborations with pharmaceutical companies, device manufacturers, and insurance providers (including referral fees and revenue-sharing).
Corporate Healthcare Contracts: Agreements with businesses to provide healthcare benefits to employees.
Advertising and Sponsored Content: Monetization through targeted advertising and sponsored content on the CureBay platform.
B2C: Direct services to individual patients in rural and small-town India.
B2B: Partnerships with corporates and healthcare ecosystem players for employee health programs and integrated care solutions.
Geographic Expansion: Scaling its e-clinic network into new states and rural districts.
Technology Investment: Enhancing its proprietary platform with AI and data analytics for predictive and personalized care.
Partnerships: Collaborating with hospitals, diagnostic labs, and pharmaceutical companies to broaden service offerings and reach.
Talent Acquisition: Building specialized teams to support technology, operations, and on-ground execution.
$35.3 Million
0
$21 Million, Series B
as of May 20, 2025
-
as of N/A
-
as of N/A
Elevar Equity
and 2 more198
Orange health
N/A
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
May 20, 2025 | Series B | $21 Million | - | - | - | Bertelsmann India Investments |
January 6, 2024 | Series A | $7.4 Million | - | - | - | Elevar Equity |
October 19, 2022 | Series A | $6.1 Million | - | - | - | Elevar Equity, InCred Capital |